(HII) Huntington Ingalls - Ratings and Ratios
Ships, Submarines, Carriers, Nuclear, Support
Dividends
| Dividend Yield | 1.66% |
| Yield on Cost 5y | 3.47% |
| Yield CAGR 5y | 5.55% |
| Payout Consistency | 100.0% |
| Payout Ratio | 37.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 27.3% |
| Value at Risk 5%th | 38.2% |
| Relative Tail Risk | -15.06% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.60 |
| Alpha | 65.49 |
| CAGR/Max DD | 0.33 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.316 |
| Beta | 0.536 |
| Beta Downside | 0.503 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.21% |
| Mean DD | 11.72% |
| Median DD | 8.35% |
Description: HII Huntington Ingalls October 31, 2025
Huntington Ingalls Industries (NYSE:HII) is the United States’ largest shipbuilder for the U.S. Navy and Coast Guard, operating through three segments-Ingalls, Newport News, and Mission Technologies. It constructs non-nuclear vessels such as amphibious assault ships, expeditionary warfare ships, surface combatants, and national-security cutters, while also delivering nuclear-powered aircraft carriers, submarines, and associated refueling, overhaul, and inactivation services. The firm further provides naval nuclear support, C5ISR systems, AI-driven battlefield tools, cyber-electronic warfare capabilities, uncrewed autonomous platforms, and comprehensive fleet sustainment solutions.
Key metrics that shape HII’s outlook include a FY 2023 revenue of roughly $11.3 billion and an order backlog exceeding $30 billion, which underpins near-term cash flow. The company’s earnings margin has hovered around 6-7 % after adjusting for one-time ship-yard cost overruns. Its performance is tightly linked to U.S. defense spending trends-particularly the Navy’s FY 2025 shipbuilding plan that earmarks over $15 billion for new carriers and surface combatants-and to macro-level inputs such as steel prices and skilled-labor availability, both of which can materially affect contract profitability.
For a deeper dive into how HII’s backlog dynamics and defense-budget outlook translate into valuation signals, you might explore the analyst tools on ValueRay to see the latest forward-looking metrics.
Piotroski VR‑10 (Strict, 0-10) 4.5
| Net Income (569.0m TTM) > 0 and > 6% of Revenue (6% = 720.7m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 2.75pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.13% (prev -6.04%; Δ 9.17pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.08 (>3.0%) and CFO 937.0m > Net Income 569.0m (YES >=105%, WARN >=100%) |
| Net Debt (2.61b) to EBITDA (1.14b) ratio: 2.29 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (39.4m) change vs 12m ago -0.25% (target <= -2.0% for YES) |
| Gross Margin 12.52% (prev 13.84%; Δ -1.32pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 102.7% (prev 105.6%; Δ -2.94pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.70 (EBITDA TTM 1.14b / Interest Expense TTM 106.0m) >= 6 (WARN >= 3) |
Altman Z'' 2.86
| (A) 0.03 = (Total Current Assets 3.08b - Total Current Liabilities 2.70b) / Total Assets 12.31b |
| (B) 0.44 = Retained Earnings (Balance) 5.38b / Total Assets 12.31b |
| (C) 0.07 = EBIT TTM 816.0m / Avg Total Assets 11.70b |
| (D) 0.73 = Book Value of Equity 5.36b / Total Liabilities 7.33b |
| Total Rating: 2.86 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 63.79
| 1. Piotroski 4.50pt |
| 2. FCF Yield 5.48% |
| 3. FCF Margin 6.85% |
| 4. Debt/Equity 0.59 |
| 5. Debt/Ebitda 2.29 |
| 6. ROIC - WACC (= 0.89)% |
| 7. RoE 11.79% |
| 8. Rev. Trend 72.71% |
| 9. EPS Trend 10.43% |
What is the price of HII shares?
Over the past week, the price has changed by +7.33%, over one month by +3.29%, over three months by +19.53% and over the past year by +75.31%.
Is HII a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 8
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the HII price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 331.9 | 1.5% |
| Analysts Target Price | 331.9 | 1.5% |
| ValueRay Target Price | 407.9 | 24.8% |
HII Fundamental Data Overview December 06, 2025
P/E Trailing = 21.7848
P/E Forward = 17.3611
P/S = 1.0319
P/B = 2.4347
P/EG = 0.9865
Beta = 0.367
Revenue TTM = 12.01b USD
EBIT TTM = 816.0m USD
EBITDA TTM = 1.14b USD
Long Term Debt = 2.70b USD (from longTermDebt, last quarter)
Short Term Debt = 503.0m USD (from shortTermDebt, last fiscal year)
Debt = 2.93b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.61b USD (from netDebt column, last quarter)
Enterprise Value = 15.01b USD (12.40b + Debt 2.93b - CCE 312.0m)
Interest Coverage Ratio = 7.70 (Ebit TTM 816.0m / Interest Expense TTM 106.0m)
FCF Yield = 5.48% (FCF TTM 823.0m / Enterprise Value 15.01b)
FCF Margin = 6.85% (FCF TTM 823.0m / Revenue TTM 12.01b)
Net Margin = 4.74% (Net Income TTM 569.0m / Revenue TTM 12.01b)
Gross Margin = 12.52% ((Revenue TTM 12.01b - Cost of Revenue TTM 10.51b) / Revenue TTM)
Gross Margin QoQ = 12.34% (prev 12.82%)
Tobins Q-Ratio = 1.22 (Enterprise Value 15.01b / Total Assets 12.31b)
Interest Expense / Debt = 0.79% (Interest Expense 23.0m / Debt 2.93b)
Taxrate = 28.92% (59.0m / 204.0m)
NOPAT = 580.0m (EBIT 816.0m * (1 - 28.92%))
Current Ratio = 1.14 (Total Current Assets 3.08b / Total Current Liabilities 2.70b)
Debt / Equity = 0.59 (Debt 2.93b / totalStockholderEquity, last quarter 4.98b)
Debt / EBITDA = 2.29 (Net Debt 2.61b / EBITDA 1.14b)
Debt / FCF = 3.18 (Net Debt 2.61b / FCF TTM 823.0m)
Total Stockholder Equity = 4.83b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.62% (Net Income 569.0m / Total Assets 12.31b)
RoE = 11.79% (Net Income TTM 569.0m / Total Stockholder Equity 4.83b)
RoCE = 10.84% (EBIT 816.0m / Capital Employed (Equity 4.83b + L.T.Debt 2.70b))
RoIC = 7.46% (NOPAT 580.0m / Invested Capital 7.78b)
WACC = 6.57% (E(12.40b)/V(15.32b) * Re(7.99%) + D(2.93b)/V(15.32b) * Rd(0.79%) * (1-Tc(0.29)))
Discount Rate = 7.99% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: -33.33 | Cagr: -0.38%
[DCF Debug] Terminal Value 78.73% ; FCFE base≈668.2m ; Y1≈689.0m ; Y5≈777.2m
Fair Price DCF = 348.4 (DCF Value 13.67b / Shares Outstanding 39.2m; 5y FCF grow 3.14% → 3.0% )
EPS Correlation: 10.43 | EPS CAGR: 5.69% | SUE: 0.24 | # QB: 0
Revenue Correlation: 72.71 | Revenue CAGR: 4.80% | SUE: 1.51 | # QB: 2
EPS next Quarter (2026-03-31): EPS=3.84 | Chg30d=+0.022 | Revisions Net=+1 | Analysts=4
EPS next Year (2026-12-31): EPS=17.35 | Chg30d=+0.320 | Revisions Net=+7 | Growth EPS=+14.8% | Growth Revenue=+5.3%
Additional Sources for HII Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle